Skip to main content

Mani Foroohar

Stock Analyst at Leerink Partners

Total Price Targets
14
Stocks Covered
12
Sectors
Healthcare
Most Recent
Mar 12, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • LXEO+142.4%
    Lexeo Therapeutics, Inc. Common Stock
    $20.00 targetOct 7, 2025
  • TNYA+110.5%
    Tenaya Therapeutics, Inc.
    $2.00 targetMar 12, 2026
  • FDMT+47.8%
    4D Molecular Therapeutics, Inc.
    $17.00 targetOct 31, 2025

Most Bearish

  • ALNY-12.1%
    Alnylam Pharmaceuticals, Inc.
    $351.00 targetDec 15, 2025
  • BBIO+6.9%
    BridgeBio Pharma, Inc.
    $68.00 targetOct 27, 2025
  • MIRM+27.2%
    Mirum Pharmaceuticals, Inc.
    $118.00 targetFeb 26, 2026

Stocks Covered by Mani Foroohar

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
BBIOBridgeBio Pharma, Inc.$98.00$69.25+41.5%3Mar 12, 2026
TNYATenaya Therapeutics, Inc.$2.00$0.72+178.9%1Mar 12, 2026
MIRMMirum Pharmaceuticals, Inc.$118.00$97.47+21.1%1Feb 26, 2026
ALNYAlnylam Pharmaceuticals, Inc.$351.00$297.62+17.9%1Dec 15, 2025
RGNXREGENXBIO Inc.$20.00$9.14+118.8%1Dec 15, 2025
FDMT4D Molecular Therapeutics, Inc.$17.00$9.17+85.4%1Oct 31, 2025
LXEOLexeo Therapeutics, Inc. Common Stock$20.00$5.82+243.6%1Oct 7, 2025
CAMPCAMP4 Therapeutics Corporation$17.00$4.08+316.7%1Nov 5, 2024
BNTCBenitec Biopharma Inc.$13.00$11.98+8.5%1Oct 14, 2024
ENGNenGene Holdings Inc.$17.00$7.24+134.8%1Sep 27, 2024
IONSIonis Pharmaceuticals, Inc.$62.00$75.86-18.3%1Jul 24, 2024
SDGRSchrödinger, Inc.$29.00$12.37+134.5%1Jul 2, 2024

Recent Activity

  • Mar 12, 2026— Set$98.00price target onBBIO(BridgeBio Pharma, Inc.)
  • Mar 12, 2026— Set$2.00price target onTNYA(Tenaya Therapeutics, Inc.)
  • Feb 26, 2026— Set$118.00price target onMIRM(Mirum Pharmaceuticals, Inc.)
  • Dec 15, 2025— Set$351.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
  • Dec 15, 2025— Set$20.00price target onRGNX(REGENXBIO Inc.)
  • Oct 31, 2025— Set$17.00price target onFDMT(4D Molecular Therapeutics, Inc.)
  • Oct 27, 2025— Set$68.00price target onBBIO(BridgeBio Pharma, Inc.)
  • Oct 7, 2025— Set$20.00price target onLXEO(Lexeo Therapeutics, Inc. Common Stock)
  • Nov 5, 2024— Set$17.00price target onCAMP(CAMP4 Therapeutics Corporation)
  • Oct 17, 2024— Set$46.00price target onBBIO(BridgeBio Pharma, Inc.)
  • Oct 14, 2024— Set$13.00price target onBNTC(Benitec Biopharma Inc.)
  • Sep 27, 2024— Set$17.00price target onENGN(enGene Holdings Inc.)
  • Jul 24, 2024— Set$62.00price target onIONS(Ionis Pharmaceuticals, Inc.)
  • Jul 2, 2024— Set$29.00price target onSDGR(Schrödinger, Inc.)

Frequently Asked Questions

Who is Mani Foroohar?

Mani Foroohar is a stock analyst at Leerink Partners covering 12 stocks primarily in Healthcare. They have issued 14 price targets since Jul 2, 2024.

What stocks does Mani Foroohar cover?

Mani Foroohar currently covers 12 stocks, including BBIO, TNYA, MIRM, ALNY, RGNX.

What is Mani Foroohar's latest price target?

Mani Foroohar's most recent price target was $98.00 on BBIO (BridgeBio Pharma, Inc.), set on Mar 12, 2026.

What is Mani Foroohar's highest price target?

Mani Foroohar's highest issued price target is $351.00 on ALNY, set on Dec 15, 2025.

Coverage based on publicly published price targets. Not investment advice.